Key Findings:  Results demonstrate that β-caryophyllene has a cholesterol-lowering effect on hypercholesterolemic rats, thus offering protection against hypercholesterolemia-induced diseases such as atherosclerosis and fatty liver. A dose of 30 mg/kg of β-caryophyllene significantly lowered serum total cholesterol, low density lipoprotein and the atherogenic index and significantly increased high density lipoprotein level.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Jordan
Year of Pub:  2018
Cannabinoids Studied: 
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2, PPAR - Alpha
Dosage: β-caryophyllene (30, 100 and 300 mg/kg b.w. for 4 weeks)
Route of Administration:  Oral (Ingestion)